The infl ammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis, are chronic infl ammatory disorders caused by dysregulated immune responses in genetically predisposed individuals. Although the precise etiology of IBD remains unclear, accumulating data, including genome-wide association studies, have advanced our understanding of its immunopathogenesis. This review highlights the role in gut homeostasis and IBD pathogenesis of autophagy, the interleukin (IL)-23/IL-17 axis, and a novel member of the tumor necrosis factor family, TL1A. It focuses on advances in our understanding of IBD from the past year, including advances in genetics and immunobiology.
Introduction
Crohn's disease (CD) and ulcerative colitis (UC) are complex polygenic conditions that are caused by dysregulated activation of effector immunologic pathways in genetically predisposed individuals. Multiple genetic factors contribute to susceptibility to infl ammatory bowel disease (IBD). Combined with recent key technologic advances, better understanding of genetic variation within the human genome has lead to the development of genome-wide association studies (GWAS) to identify genetic risk factors for complex polygenic disease in an unbiased manner.
The main genetic associations in IBD can be divided into genes that contribute to innate and adaptive immune responses. In the innate immune arm, the association of CD with polymorphisms in NOD2 (CARD15) and the two autophagy-related genes, ATG16L1 and IRGM, implicate defects in the recognition and handling of intracellular bacteria in the immunopathogenesis of IBD. In the adaptive immune arm, CD has been considered a T-helper-1 (Th1) condition mediated by the interleukin (IL)-12/interferon (IFN)-γ/tumor necrosis factor (TNF) cytokine axis (reviewed in [1] ). In contrast, the T-cell response in UC appears to be Th2-dominant 
Genome-Wide Association Studies
As a result of recent advances in genetic statistical theory, the availability of cheap, high-throughput genotyping, and the development of the HapMap, researchers are now able to perform genetic association studies on a scale that until recently was thought to be impossible. Within the past few years, numerous GWAS have been published in an increasing number of genetically complex diseases, with CD leading the way. GWAS look at tens of thousands to hundreds of thousands of single nucleotide polymorphisms (SNPs) across the human genome in both individuals with disease and healthy controls. The allele frequencies of these SNPs in the cases and controls are statistically compared to identify any association between a SNP and the disease or condition in question. Independent confi rmation of association is needed for fi ndings generated in a GWAS. It is also important to understand that most SNPs included in a GWAS are chosen for methodologic genotyping reasons, not for their perceived function. Therefore, any confi rmed SNP associations that are seen with a GWAS are likely to be in linkage disequilibrium with a true disease susceptibility allele rather than being the causal allele itself, unless the researchers have been extremely fortunate. Details of GWAS performed in IBD are listed in Table 2 [2-9,10••].
More recently, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the Wellcome Trust Case Control Consortium (WTCCC), and the Franco-Belgian GWAS group have pooled their data to perform a meta-analysis [10••] . Using this data set with strict statistical criteria and independent replication, the group have identifi ed 30 genetic loci that are associated with CD. These associations are listed in Table 2 . Remarkably, these genetic variants account for only 20% of the genetic susceptibility to CD in this population, suggesting that a considerable amount of genetic research remains to be done.
Innate Immunity
Antigen presentation to T cells by professional antigenpresenting cells (APCs) such as dendritic cells (DCs) is critical for the activation of adaptive immune responses. There are three main pathways to transport luminal antigen to lamina propria (LP). The fi rst pathway is mediated by microfold cells through the capture of luminal antigens and their presentation to T cells. The second pathway, performed by LP DCs, involves dendritic cell extension to the intestinal lumen across epithelial cells, facilitating the capture of luminal antigens (Fig. 1) . The third pathway involves the neonatal Fc receptor (FcRn), which serves as the vehicle for transporting LP immunoglobulin G (IgG) across the colonic epithelial layer into the lumen, where the IgG can bind enteric bacterial antigens to form immune complexes (IC). The FcRn then recycles the antigens/IgG IC back across the colonic epithelial cells into the LP for processing by APCs (eg, DCs), which can present the antigens to T cells.
One of the ways that the host distinguishes foreign from self antigen is through a pattern recognition receptor (PRR), which recognizes specifi c molecular patterns of pathogens. One group of PRRs is the Toll-like receptors (TLRs), which have variable specifi cities for sensing microbial products. TLR activation can stimulate signaling cascades leading to proinfl ammatory cytokine production and induction of co-stimulatory signals to initiate effector adaptive immune response (Fig. 1) . Nucleotide oligomerization domain (NOD) proteins are cytosolic PRRs involved in the intracellular recognition of bacterial products. The identifi cation of NOD2 as a CD susceptibility gene indicates defective innate immune responses and implicates the role of altered intracellular processing of bacterial components in IBD. Recent genetic associations between autophagy genes, NOD2, and CD further highlight the importance of intracellular processing of bacterial components in mucosal homeostasis.
Defects in autophagy associated with Crohn's disease
Autophagy, from the Greek words auto (oneself) and phagy (to eat), is a biologic process of membrane traffi cking in which autophagosomes engulf both organelles and cytosolic macromolecules, followed by fusion of the autophagosome with a lysosome to form an autolysosome in which sequestered material is degraded. The degraded content can then be loaded onto HLA class II molecules or to compartments where recognition by TLRs may occur. For example, a TLR4 signaling pathway was recently found to regulate autophagy associated with innate immunity [11] . Autophagy is important for cellular homeostatic functions, including structural remodeling, generating energy, degrading damaged or long-lived cytoplasmic components, and protecting against invading microorganisms. Its protective role in infectious disease is an important part of the innate immune armamentarium and links to adaptive immunity by delivering foreign antigens necessary for immune recognition. Several recent studies advance our understanding of physiological signals and molecular pathways that regulate and execute autophagy and its role in both health-promoting and disease-associated states. Notably, ATG16L1 and IRGM have been identifi ed as new CD susceptibility genes [12] [13] [14] .
The ATG16L1 gene product is comprised of an Nterminal ATG16 domain thought to be essential for interaction with other autophagy proteins such as ATG5 and ATG12, a coiled-coil domain postulated to mediate homodimeric interactions, and seven C-terminal WD repeats (tryptophan-aspartate repeats) thought to create stable platforms that can coordinate the formation of the multimeric protein complex that is essential for the formation of the autophagosome [15] . ATG16L1 is broadly expressed by intestinal epithelial cells; APCs; and CD4 + , CD8 + , and CD19 + primary human T cells [5, 12] . Given the 
